BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 24580771)

  • 1. Prevalence, incidence and risk factors for donor-specific anti-HLA antibodies in maintenance liver transplant patients.
    Del Bello A; Congy-Jolivet N; Muscari F; Lavayssière L; Esposito L; Cardeau-Desangles I; Guitard J; Dörr G; Suc B; Duffas JP; Alric L; Bureau C; Danjoux M; Guilbeau-Frugier C; Blancher A; Rostaing L; Kamar N
    Am J Transplant; 2014 Apr; 14(4):867-75. PubMed ID: 24580771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Resolved Preformed, Persistent Preformed, and De Novo Anti-HLA Donor-Specific Antibodies in Kidney Transplant Recipients on Long-Term Renal Graft Outcomes.
    Gniewkiewicz M; Czerwinska K; Zielniok K; Durlik M
    J Clin Med; 2023 May; 12(10):. PubMed ID: 37240467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Antibody-Mediated Rejection in Liver Transplant Recipients with Autoimmune Liver Disease: A Clinical and Pathologic Study of 4 Cases.
    Jiang H; Guo H; Yang B; Zhao Y; Wei L; Chen Z; Chen D
    J Pers Med; 2022 Dec; 13(1):. PubMed ID: 36675702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term liver allograft fibrosis: A review with emphasis on idiopathic post-transplant hepatitis and chronic antibody mediated rejection.
    Vij M; Rammohan A; Rela M
    World J Hepatol; 2022 Aug; 14(8):1541-1549. PubMed ID: 36157865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The New Challenge in Pediatric Liver Transplantation: Chronic Antibody-Mediated Rejection.
    Uebayashi EY; Okajima H; Yamamoto M; Ogawa E; Okamoto T; Haga H; Hatano E
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-Mediated Rejection and Recurrent Primary Disease: Two Main Obstacles in Abdominal Kidney, Liver, and Pancreas Transplants.
    Nakamura T; Shirouzu T
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study.
    Friman S; Tisone G; Nevens F; Lehner F; Santaniello W; Bechstein WO; Zhuvarel SV; Isoniemi H; Rummo OO; Klempnauer J; Anaokar S; Hurst M; Kazeem G; Undre N; Trunečka P
    Transplant Direct; 2021 Aug; 7(8):e722. PubMed ID: 34263020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of donor-specific human leukocyte antigen antibodies after pediatric liver transplantation.
    Liu W; Wang K; Xiao YL; Liu C; Gao W; Li DH
    Exp Ther Med; 2021 Aug; 22(2):867. PubMed ID: 34194545
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Beyzaei Z; Geramizadeh B; Bagheri Z; Karimzadeh S; Shojazadeh A
    Front Immunol; 2020; 11():613128. PubMed ID: 33424868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Anti-HLA Donor-Specific Antibodies Results in Increased Infectious Complications and Impairs Survival after Liver Transplantation.
    Ünlü S; Lachmann N; Jara M; Ritschl PV; Wiering L; Eurich D; Denecke C; Biebl M; Chopra S; Gül-Klein S; Schöning W; Schmelzle M; Reinke P; Tacke F; Pratschke J; Öllinger R; Dziodzio T
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33317012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity level.
    Willuweit K; Frey A; Bieniek L; Heinold A; Büchter M; Horn PA; Wedemeyer H; Herzer K
    BMC Gastroenterol; 2020 Aug; 20(1):288. PubMed ID: 32854625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Human Immune Response to Cadaveric and Living Donor Liver Allografts.
    Hann A; Osei-Bordom DC; Neil DAH; Ronca V; Warner S; Perera MTPR
    Front Immunol; 2020; 11():1227. PubMed ID: 32655558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Preformed Antibodies in Liver Transplantation.
    Legaz I; Boix F; López M; Alfaro R; Galián JA; Llorente S; Campillo JA; Botella C; Ramírez P; Sánchez-Bueno F; Pons JA; Moya-Quiles MR; Minguela A; Muro M
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32151032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring pre-surgery donor-specific antibodies in the context of organ shortage in liver transplant.
    Barreto SG; Brooke-Smith ME; Neo EL; Dolan P; Leibbrandt R; Emery T; Carroll R; Wigg A; Chen JW
    Langenbecks Arch Surg; 2019 Nov; 404(7):865-874. PubMed ID: 31748871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High tacrolimus intra-patient variability is associated with graft rejection, and
    Del Bello A; Congy-Jolivet N; Danjoux M; Muscari F; Lavayssière L; Esposito L; Hebral AL; Bellière J; Kamar N
    World J Gastroenterol; 2018 Apr; 24(16):1795-1802. PubMed ID: 29713132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the Trough Level of Calcineurin Inhibitor on the Prevalence of Donor-Specific Human Leukocyte Antigen Antibodies During Long-Term Follow-Up After Pediatric Liver Transplantation: Antibody Strength and Complement-Binding Ability.
    Tokodai K; Miyagi S; Nakanishi C; Hara Y; Nakanishi W; Goto M; Unno M; Kamei T
    Transplant Direct; 2017 Aug; 3(8):e196. PubMed ID: 28795147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies.
    Valenzuela NM; Reed EF
    J Clin Invest; 2017 Jun; 127(7):2492-2504. PubMed ID: 28604384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.
    Avila CL; Zimmerer JM; Elzein SM; Pham TA; Abdel-Rasoul M; Bumgardner GL
    Transplantation; 2016 Sep; 100(9):1898-906. PubMed ID: 27362313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive Fibrosis Is Driven by Genetic Predisposition, Allo-immunity, and Inflammation in Pediatric Liver Transplant Recipients.
    Varma S; Ambroise J; Komuta M; Latinne D; Baldin P; Reding R; Smets F; Stephenne X; Sokal EM
    EBioMedicine; 2016 Jul; 9():346-355. PubMed ID: 27333038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically relevant interpretation of solid phase assays for HLA antibody.
    Bettinotti MP; Zachary AA; Leffell MS
    Curr Opin Organ Transplant; 2016 Aug; 21(4):453-8. PubMed ID: 27200498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.